COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems

NeuroImage

Volumn 55, Issue 1, 2011, Pages 338-344

  Swart, Marte ^a   Bruggeman, Richard ^a   Larøi, Frank ^b   Alizadeh, Behrooz Z ^a   Kema, Ido ^a   Kortekaas, Rudie ^a   Wiersma, Durk ^a   Aleman, André ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cingulate cortex; COMT; Emotion; Emotional verbalizing; FMRI; Valence evaluation

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; AFFECT; ALLELE; ARTICLE; BRAIN REGION; COGNITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMOTIONALITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; MOOD DISORDER; NORMAL HUMAN; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; QUESTIONNAIRE; VERBALIZATION;

BRAIN; CATECHOL O-METHYLTRANSFERASE; EMOTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; VERBAL BEHAVIOR; YOUNG ADULT;

EID: 78951493474     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.12.017     Document Type: Article

References (67)

1. Abdolmaleky H.M. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2006, 15(21):3132-3145.
2. Aleman A., Formisano E., et al. The functional neuroanatomy of metrical stress evaluation of perceived and imagined spoken words. Cereb. Cortex 2005, 15(2):221-228.
3. Aleman A., Swart M., et al. Brain imaging, genetics and emotion. Biol. Psychol. 2008, 79(1):58-69.
4. Bach M. Predictive value of alexithymia: a prospective study in somatizing patients. Psychother. Psychosom. 1995, 64(1):43-48.
5. Berthoz S., Ouhayoun B., et al. Comparison of the psychometric properties of two self-report questionnaires measuring alexithymia: confirmatory factor analysis of the 20-item Toronto Alexithymia Scale and the Bermond-Vorst Alexithymia Questionnaire. Eur. Rev. Appl. Psychol. 2000, 50(4):359-368.
6. Berthoz S., Perdereau F., et al. Observer- and self-rated alexithymia in eating disorder patients: levels and correspondence among three measures. J. Psychosom. Res. 2007, 62(3):341-347.
7. Bertolino A., Rubino V., et al. Prefrontal-hippocampal coupling during memory processing is modulated by COMT Val158Met genotype. Biol. Psychiatry 2006, 60(11):1250-1258.
8. Bishop S.J., Cohen J.D., et al. COMT genotype influences prefrontal response to emotional distraction. Cogn. Affect. Behav. Neurosci. 2006, 6(1):62-70.
9. Chen J.S., Lipska B.K., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004, 75(5):807-821.
10. Cohen, H., Neumann L., et al. (2009). The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin. Exp. Rheumatol. 27 (5 Suppl 56), S51-S56.
11. Davidson, R.J., Putnam, K.M., et al. (2000). Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 289 (5479), 591-594.
12. Dimaggio G., Vanheule S., et al. Impaired self-reflection in psychiatric disorders among adults: a proposal for the existence of a network of semi independent functions. Conscious. Cogn. 2009, 18(3):653-664.
13. Domschke K., Freitag C.M., et al. Association of the functional Val158Met catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol. 2004, 7(02):183-188.
14. Drabant E.M., Hariri A.R., et al. Catechol O-methyltransferase val(158)met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry 2006, 63(12):1396-1406.
15. Egan M.F., Goldberg T.E., et al. Effect of COMT Val(108/158) Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA 2001, 98(12):6917-6922.
16. Eley T.C., Tahir E., et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120B(1):90-96.
17. Enoch M.A., Xu K., et al. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr. Genet. 2003, 13(1):33-41.
18. Finan, P.H.P., Zautra, A.J.A., et al. (2010). Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol. 29 (2), 134-142. Erratum in: Health Psychol. 29 (3), 245.
19. Goldberg T.E., Egan M.F., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 2003, 60(9):889-896.
20. Ham B.J., Lee M.S., et al. Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia. Neuropsychobiology 2005, 52(3):151-154.
21. Heinz A., Smolka M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci. 2006, 17(3):359-367.
22. Honkalampi K., Hintikka J., et al. Depression is strongly associated with alexithymia in the general population. J. Psychosom. Res. 2000, 48(1):99-104.
23. Huber A., Suman A.L., et al. Alexithymia in fibromyalgia syndrome: associations with ongoing pain, experimental pain sensitivity and illness behavior. J. Psychosom. Res. 2009, 66(5):425-433.
24. Kempton M.J., Haldane M., et al. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int. J. Neuropsychopharmacol. 2009, 12(3):371-381.
25. Lachman H.M., Papolos D.F., et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6(3):243-250.
26. Lane R.D., Sechrest L., et al. Impaired verbal and nonverbal emotion recognition in alexithymia. Psychosom. Med. 1996, 58(3):203-210.
27. Lane R.D., Ahern G.L., et al. Is alexithymia the emotional equivalent of blindsight?. Biol. Psychiatry 1997, 42(9):834-844.
28. Lee K.H., Siegle G.J. Common and distinct brain networks underlying explicit emotional evaluation: a meta-analytic study. Soc. Cogn. Affect. Neurosci. 2009, 10.1093/scan/nsp001.
29. Lelli-Chiesa G., Kempton M.J., Jogia J., Tatarelli R., Girardi P., Powell J., Collier D.A., Frangou S. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol. Med. 2010, 1-10.
30. Lopez-Leon S., Janssens A.C.J.W., et al. Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 2008, 13(8):772-785.
31. Luminet O., Vermeulen N., et al. Alexithymia and levels of processing: evidence for an overall deficit in remembering emotion words. J. Res. Pers. 2006, 40(5):713-733.
32. Maddock R.J. The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci. 1999, 22(7):310-316.
33. Maddock R.J., Garrett A.S., et al. Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task. Hum. Brain Mapp. 2003, 18(1):30-41.
34. Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 51(4):593-628.
35. Mantani T., Okamoto Y., et al. Reduced activation of posterior cingulate cortex during imagery in subjects with high degrees of alexithymia: a functional magnetic resonance imaging study. Biol. Psychiatry 2005, 57(9):982-990.
36. Mattila A.K. Alexithymia and somatization in general population. Psychosom. Med. 2008, 70(6):716-722.
37. McIntosh A.M., Baig B.J., et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol. Psychiatry 2007, 61(10):1127-1134.
38. Mier, D., P. Kirsch, et al., 2010. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry 15 (9), 918-927.
39. Montag C., Hartmann P., et al. COMT genetic variation affects fear processing: psychophysiological evidence. Behav. Neurosci. 2008, 122(4):901-909.
40. Mynett-Johnson L.A., Murphy V.E., et al. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr. Genet. 1998, 8(4):221-225.
41. Nemiah J.C., Sifneos P.E. Psychosomatic illness - problem in communication. Psychother. Psychosom. 1970, 18(1-6):154-160.
42. Northoff G., Heinzel A., et al. Self-referential processing in our brain - a meta-analysis of imaging studies on the self. Neuroimage 2006, 31(1):440-457.
43. Norusius (2002). Statistical Package for the Social Sciences (SPSS).
44. Okochi T. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr. Res. 2009, 110(1-3):140-148.
45. Papolos D.F., Veit S., et al. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol. Psychiatry 1998, 3(4):346-349.
46. Paradiso S., Johnson D.L., et al. Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects. Am. J. Psychiatry 1999, 156(10):1618-1629.
47. Posner J., Russell J.A., et al. The neurophysiological bases of emotion: an fMRI study of the affective circumplex using emotion-denoting words. Hum. Brain Mapp. 2009, 30(3):883-895.
48. Raichle M.E., MacLeod A.M., et al. A default mode of brain function. Proc. Natl Acad. Sci. USA 2001, 98(2):676-682.
49. Sifneos P.E. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother. Psychosom. 1973, 22(2):255-262.
50. Slifstein M., Kolachana B., et al. COMT genotype predicts cortical-limbic D1 receptor availability measured with [C-11]NNC112 and PET. Mol. Psychiatry 2008, 13(8):821-827.
51. Smolka M.N., Schumann G., et al. Catechol-O-methyltransferase val(158)met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 2005, 25(4):836-842.
52. Suslow T. Alexithymia and automatic affective processing. Eur. J. Pers. 1998, 12(6):433-443.
53. Svoboda E., McKinnon M.C., et al. The functional neuroanatomy of autobiographical memory: a meta-analysis. Neuropsychologia 2006, 44(12):2189-2208.
54. Swart M., Kortekaas R., et al. Dealing with feelings: characterization of trait alexithymia on emotion regulation strategies and cognitive-emotional processing. PLoS ONE 2009, 4(6):e5751.
55. Taylor G.J., Bagby R.M., et al. Disorders of Affect Regulation Alexithymia in Medical and Psychiatric Illness 1997, Cambridge University Press, Cambridge.
56. van der Meer L., Costafreda S., et al. Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia. Neurosci. Biobehav. Rev. 2010, 34(6):935-946.
57. van 't Wout M., Aleman A., et al. No words for feelings: alexithymia in schizophrenia patients and first-degree relatives. Compr. Psychiatry 2007, 48(1):27-33.
58. Vermeulen N., Luminet O., et al. Alexithymia and the automatic processing of affective information: evidence from the affective priming paradigm. Cogn. Emotion 2006, 20(1):64-91.
59. Vermeulen N., Luminet O., et al. Categorical perception of anger is disrupted in alexithymia: evidence from a visual ERP study. Cogn. Emotion 2008, 22(6):1052-1067.
60. Vorst H.C.M., Bermond B. Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Pers. Individ. Differ. 2001, 30:413-434.
61. Watson D., Clark L.A., et al. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54(6):1063-1070.
62. Waugh C.E., Dearing K.F., et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and self-perceived social acceptance in adolescent girls. J. Child Adolesc. Psychopharmacol. 2009, 19(4):395-401.
63. Weiss E.M., Stadelmann E., et al. Differential effect of catechol-O-methyltransferase Val(158) Met genotype on emotional recognition abilities in healthy men and women. J. Int. Neuropsychol. Soc. 2007, 13(5):881-887.
64. Williams, L. M., J. M. Gatt, et al., 2010. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage 53 (3), 918-925.
65. Woo J.M., Yoon K.S., et al. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J. Psychiatr. Res. 2007, 38(4):365-370.
66. Zech E., Luminet O., et al. Alexithymia and its measurement: confirmatory factor analyses of the 20-item Toronto Alexithymia Scale and the Bermond-Vorst Alexithymia Questionnaire. Eur. J. Pers. 1999, 13(6):511-532.
67. Zubieta J.K., Heitzeg M.M., et al. COMT val(158)met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299(5610):1240-1243.